Skip to main content
Clinical Trials/EUCTR2007-004074-10-IT
EUCTR2007-004074-10-IT
Active, Not Recruiting
N/A

?Idiopathic sudden sensorineural hearing loss treatment by Infliximab injection (TNF-alfa blocker)? - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesJanuary 4, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Status
Active, Not Recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2008
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Eligibility Criteria

Inclusion Criteria

  • idiopathic sudden sensorineural hearing loss (severe or profound pure tone average) no responders to protocol therapy; caucasian race subjects; age range 20\-80 years; female and males.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • familiar history of hearing loss; immunodeficiency disease; severe heart and vascular disease; pharmacological intolerance; cases responders to protocol therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials